115 related articles for article (PubMed ID: 31188741)
1. TMEM100 expression suppresses metastasis and enhances sensitivity to chemotherapy in gastric cancer.
Zhuang J; Huang Y; Zheng W; Yang S; Zhu G; Wang J; Lin X; Ye J
Biol Chem; 2020 Feb; 401(2):285-296. PubMed ID: 31188741
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.
Ge Y; Li Q; Lin L; Jiang M; Shi L; Wang B; Yang L; Xu Z
Cell Biochem Funct; 2020 Jan; 38(1):28-37. PubMed ID: 31710389
[TBL] [Abstract][Full Text] [Related]
3. RAB13 as a novel prognosis marker promotes proliferation and chemotherapeutic resistance in gastric cancer.
Chen P; Chen G; Wang C; Mao C
Biochem Biophys Res Commun; 2019 Oct; 519(1):113-120. PubMed ID: 31474334
[TBL] [Abstract][Full Text] [Related]
4. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
6. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
7. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
8. Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment.
Jiang XY; Zhu XS; Xu HY; Zhao ZX; Li SY; Li SZ; Cai JH; Cao JM
Acta Pharmacol Sin; 2017 Jul; 38(7):1048-1058. PubMed ID: 28344324
[TBL] [Abstract][Full Text] [Related]
9. CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancer.
Wang B; Zheng J; Chen Q; Wu C; Li Y; Yu XY; Liu B; Liang C; Liu SB; Ding H; Wang S; Xue T; Song D; Lei Z; Amin HM; Song YH; Zhou J
Carcinogenesis; 2020 Jul; 41(6):841-849. PubMed ID: 31560739
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer.
Nam HJ; Im SA; Oh DY; Elvin P; Kim HP; Yoon YK; Min A; Song SH; Han SW; Kim TY; Bang YJ
Mol Cancer Ther; 2013 Jan; 12(1):16-26. PubMed ID: 23144237
[TBL] [Abstract][Full Text] [Related]
11. Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.
Yu S; Li Q; Yu Y; Cui Y; Li W; Liu T; Liu F
Cancer Immunol Immunother; 2020 Oct; 69(10):1973-1987. PubMed ID: 32388677
[TBL] [Abstract][Full Text] [Related]
12. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
Chen D; Cao G; Liu Q
J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
[TBL] [Abstract][Full Text] [Related]
13. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
14. Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway.
Hou G; Yuan X; Li Y; Hou G; Liu X
Invest New Drugs; 2020 Apr; 38(2):329-339. PubMed ID: 31102118
[TBL] [Abstract][Full Text] [Related]
15. A novel design of HA-coated nanoparticles co-encapsulating plasmid METase and 5-Fu shows enhanced application in targeting gastric cancer stem cells.
Yang W; Zhang H; Xin L
Biol Chem; 2018 Feb; 399(3):293-303. PubMed ID: 29016350
[TBL] [Abstract][Full Text] [Related]
16. eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/β-catenin in gastric cancer.
Zhai S; Lin S; Lin Z; Xu J; Ji T; Chen K; Wu K; Liu H; Ying H; Fei W; Wang J; Fu G; Wang Y; Hu X; Cai X
Gastric Cancer; 2020 May; 23(3):483-496. PubMed ID: 31853750
[TBL] [Abstract][Full Text] [Related]
17. PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.
Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP
Mol Cancer Ther; 2020 Mar; 19(3):906-919. PubMed ID: 31879364
[TBL] [Abstract][Full Text] [Related]
18. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
19. Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma.
Ou D; Yang H; Hua D; Xiao S; Yang L
Oncotarget; 2015 Jul; 6(19):17379-90. PubMed ID: 25978032
[TBL] [Abstract][Full Text] [Related]
20. MACC1 mediates chemotherapy sensitivity of 5-FU and cisplatin via regulating MCT1 expression in gastric cancer.
Wang C; Wen Z; Xie J; Zhao Y; Zhao L; Zhang S; Liu Y; Xue Y; Shi M
Biochem Biophys Res Commun; 2017 Apr; 485(3):665-671. PubMed ID: 28235486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]